Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Comorbidities in interstitial lung diseases.

Margaritopoulos GA, Antoniou KM, Wells AU.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160027. doi: 10.1183/16000617.0027-2016. Print 2017 Jan. Review.

2.

Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.

Schwarzkopf L, Witt S, Waelscher J, Polke M, Kreuter M.

Respir Res. 2018 Apr 25;19(1):73. doi: 10.1186/s12931-018-0769-0.

3.

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.

Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park JS, Poonyagariyagorn HK, Wuyts W, Wells AU.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180076. doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31. Review.

4.

Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.

King C, Nathan SD.

Curr Opin Pulm Med. 2013 Sep;19(5):466-73. doi: 10.1097/MCP.0b013e328363f460. Review.

PMID:
23912191
5.

An integrated approach in the diagnosis of smoking-related interstitial lung diseases.

Caminati A, Cavazza A, Sverzellati N, Harari S.

Eur Respir Rev. 2012 Sep 1;21(125):207-17. doi: 10.1183/09059180.00003112.

6.

Spectrum of fibrosing diffuse parenchymal lung disease.

Morgenthau AS, Padilla ML.

Mt Sinai J Med. 2009 Feb;76(1):2-23. doi: 10.1002/msj.20087. Review.

7.

Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.

Bradley TD, Miller YE, Martinez FJ, Angus DC, Macnee W, Abraham E.

Am J Respir Crit Care Med. 2005 Apr 1;171(7):675-85. Review. No abstract available.

PMID:
15790865
8.

Interstitial lung disease.

Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V.

Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Review.

9.

Smoking-related interstitial lung diseases.

Nagai S, Hoshino Y, Hayashi M, Ito I.

Curr Opin Pulm Med. 2000 Sep;6(5):415-9. Review.

PMID:
10958232
10.

Idiopathic inflammatory myopathies and the lung.

Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V.

Eur Respir Rev. 2015 Jun;24(136):216-38. doi: 10.1183/16000617.00002015. Review. Erratum in: Eur Respir Rev. 2015 Sep;24(137):545. Dosage error in article text.

11.

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases.

Holtze C, Flaherty K, Kreuter M, Luppi F, Moua T, Vancheri C, Scholand MB.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180078. doi: 10.1183/16000617.0078-2018. Print 2018 Dec 31. Review.

12.

[Comorbidity diseases in adults with diagnosed interstitial lung diseases among inhabitants of the Silesian voivodeship, Poland].

Niewiadomska E, Kowalska M, Zejda JE.

Med Pr. 2016 Dec 22;67(6):751-763. doi: 10.13075/mp.5893.00487. Epub 2016 Nov 22. Polish.

13.

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.

Olson AL, Gifford AH, Inase N, Fernández Pérez ER, Suda T.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180077. doi: 10.1183/16000617.0077-2018. Print 2018 Dec 31. Review.

14.

Interstitial lung disease in systemic sclerosis.

Bussone G, Mouthon L.

Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21. Review.

PMID:
20863911
15.

[Interstitial lung diseases--problem of ageing societies].

Golec M, Władysiuk-Blicharz M, Spiewak R.

Pol Merkur Lekarski. 2007 Oct;23(136):288-90. Review. Polish.

PMID:
18293853
16.
17.

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.

Swigris JJ, Brown KK, Abdulqawi R, Buch K, Dilling DF, Koschel D, Thavarajah K, Tomic R, Inoue Y.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180075. doi: 10.1183/16000617.0075-2018. Print 2018 Dec 31. Review.

18.

Update in diffuse parenchymal lung diseases 2005.

Martinez FJ, Keane MP.

Am J Respir Crit Care Med. 2006 May 15;173(10):1066-71. Review. No abstract available.

PMID:
16679445
19.

Interstitial lung disease and gastroesophageal reflux.

Ing AJ.

Am J Med. 2001 Dec 3;111 Suppl 8A:41S-44S. Review.

PMID:
11749923
20.

Prevalence and prognosis of unclassifiable interstitial lung disease.

Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE Jr, Wolters PJ, Collard HR.

Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.

Supplemental Content

Support Center